Back

Three decades of lipid-lowering therapy in type 2 diabetic patients with angiographically proven stable coronary artery disease

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Medical and percutaneous treatment of coronary artery disease Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speakers

Photo
Professor Heinz Drexel

Vorarlberg Institute for Vascular Investigation and Treatment, Feldkirch (Austria)

Photo
Doctor Arthur Mader

VIVIT Institute, Feldkirch (Austria)

7 More presentations in this session

Presentation thumbnail
Placebo-controlled efficacy of 17 anti-anginal drugs and percutaneous coronary intervention for first-line treatment of stable angina: systematic review & meta-analysis of 5153 patients from 53 trials
Doctor A. Kaura (London, GB)
Abstract Slides Video
Presentation thumbnail
Persistent angina following revascularization for chronic coronary syndromes: a systematic review and meta-analysis of randomized controlled trials
Doctor A. Singh (Los Angeles, US)
Abstract Slides Video
Presentation thumbnail
Comparative meta-analysis: drug-coated balloon versus drug-coated stent - a comprehensive evaluation of efficacy and safety in stentless percutaneous coronary intervention for coronary artery disease
Slides Video
Presentation thumbnail
Effect of primary pci in asymptomatic stemi patients presenting 12 to 48 hours of symptom onset, on myocardial viability assessed by spect tc 99m sestamibi scan epitome99
Doctor M. Pandit (Bangalore, India, IN)
Abstract Slides Video
Presentation thumbnail
Impact of symptom-to-balloon time on long-term prognosis: a 3-year follow-up study in non-st-segment elevation myocardial infarction patients with complex lesions
Professor Y. Kim (Chuncheon, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Medical and percutaneous treatment of coronary artery disease

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Use of new antidiabetic drugs in patients with cardiovascular diseases - real life data
thumbnail
Congress Presentation
Changes in lipid lowering therapy one year after percutaneous coronary intervention: data from the large contemporary ZON-HR registry
thumbnail
Congress Presentation
Association between high-intensity lipid-lowering therapy and atherosclerotic plaque content changes assed by iMAP-IVUS and near-infrared spectroscopy in patients with premature atherosclerosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources